The power of tumor infiltrating lymphocyte to fight melanoma

The Labiotech podcast discusses Iovance Biotherapeutics’ Tumor Infiltrating Lymphocyte (TIL) therapy that uses a patient’s immune cells to combat advance melanoma. Iovance recently requested marketing authorization in the EU for lifileucel, a TIL cell therapy. If approved, it would be the first in this treatment for all EU member states.